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Recently we described that endonuclease inactive DNase I translocated into the nucleus
in response to increased endogenous IL-1β expression. Here, we demonstrate impact
and function of translocated DNase I in tubular cells. Effect of cytokines on expression
level and nuclear localisation of DNase I and corresponding levels of Fas receptor (FasR)
and IL-1β were determined by confocal microscopy, qPCR and western blot analyses,
in presence or absence of siRNA against IL-1β and DNase I mRNA. Nuclear DNase I
bound to the FAS promotor region as determined by chromatin immuno-precipitation
analysis. Data demonstrate that; (i) translocation of DNase I depended on endogenous
de novo-expressed IL-1β, (ii) nuclear DNase I bound FAS DNA, (iii) FasR expression
increased after translocation of DNase I, (iv) interaction of exogenous Fas ligand (FasL)
with upregulated FasR induced apoptosis in human tubular cells stimulated with TNFα.
Thus, translocated DNase I most probably binds the promoter region of the FAS gene
and function as a transcription factor for FasR. In conclusion, DNase I not only executes
chromatin degradation during apoptosis and necrosis, but also primes the cells for
apoptosis by enhancing FasR expression.
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INTRODUCTION
Chromatin fragments play a decisive role in immune complex formation with anti-double stranded
DNA (dsDNA) antibodies in lupus nephritis. Such immune complexes are detected in glomeruli as
electron dense structures (EDS) by electron microscopy, or as granula in glomerular membranes
andmatrices by immunofluorescence assays (Berden et al., 1999; Kalaaji et al., 2006; Mortensen and
Rekvig, 2009; van der Vlag and Berden, 2011; Seredkina et al., 2013). As lupus nephritis progresses
from early to advanced stages, we observed in our studies a distinct increase of chromatin deposits
in glomerular basement membranes (GBM), whereas deposits in early nephritis were confined to
the mesangial matrix. Correlating significantly in time with chromatin accumulation, we found
silencing of the gene encoding renal DNase I (Fenton et al., 2009; Seredkina et al., 2009; Seredkina
and Rekvig, 2011) that accounts for more than 80% of total renal endonuclease activity (Basnakian
et al., 2005; Zykova et al., 2008). This expression pattern of DNase I is observed consistently in
murine and human lupus nephritis (reviewed in Seredkina et al., 2013). These studies point out
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renal DNase I as a protective factor when it is expressed, whereas
DNASE1 gene silencing is related to progression of the disease
(Zykova et al., 2008; Fenton et al., 2009; Seredkina et al., 2009).
The DNase I endonuclease was described already in 1946 by
McCarthy et al. (McCarty, 1946). Despite knowing the enzyme
for seven decades, we still do not understand regulation of DNase
I expression and activity, its dynamic subcellular migration,
and localization (Choi et al., 2008), nor its role in apoptosis
and necrosis (Samejima and Earnshaw, 2005; Kawane and
Nagata, 2008), particularly in context of autoimmunity (Napirei
et al., 2000; Martinez-Valle et al., 2009). During a longitudinal
study on expression profiles in (NZBxNZW)F1 (BW) mice, we
observed a tendency for DNase I up-regulation during mesangial
nephritis, before a subsequent and distinct down-regulation
of the gene during progressive disease (Fenton et al., 2009;
Seredkina and Rekvig, 2011). In addition, we have observed
nuclear localization of renal DNase I in tubular cells in human
lupus nephritis (Thiyagarajan et al., 2015). Studies on cultured
human renal proximal tubular epithelial cells (RPTEC) have also
shown translocation of DNase I into the nucleus under certain
conditions (Thiyagarajan et al., 2015).
Detailed analyses of DNase I expression by Western blot,
gel zymography, and mass spectrometry (MS) revealed three
major variants of the DNase I protein in resting tubular cells.
Two DNase I variants were determined to be products of the
DNASE1 gene by mass spectrometry (MS) and were expressed
in the cytoplasm; one enzymatically active with molecular weight
(MW) of 40 kDa, and another enzymatically inactive with MW
around 55 kDa. The DNase I variant that translocated into
the nucleus was enzymatically inactive and differed from the
other detected DNase I molecules, as it had a MW of 52 kDa
(Thiyagarajan et al., 2015). Studies from Oliveri et al. suggested
that recombinant DNase I added to cell cultures could act as
transcriptional factor for FAS and increase the expression of
cell surface fas receptor (FasR) in human cells (Oliveri et al.,
2004). This encouraged us to analyse if nuclear DNase I acts as
a transcription factor for FAS in RPTEC.
The present study aims to describe three phenomena
linked to renal DNASE1 gene expression and subcellular
compartmentation in response to different stimuli. First, since
the DNASE1 gene tended to be upregulated in mesangial
nephritis (Fenton et al., 2009; Thiyagarajan et al., 2015), we
assumed that pro-inflammatory cytokines may be responsible
for this phenomenon. Second, the same pro-inflammatory
cytokines were expected to induce nuclear translocation of
DNase I; and third, nuclear translocated DNase I presumably
had another biological significance than to promote chromatin
degradation. This consideration is based on the fact that
translocated DNase I was demonstrated to be endonucleolytically
inactive (Thiyagarajan et al., 2015). The results presented here
confirm the rationale of this threefold idea and describe a
novel role of DNase I as a transcription factor regulating
FasR expression. These findings imply that DNase I has a
biological role as a pro-apoptotic protein that prime the cells
for apoptosis, whereas it also contributes as an endonuclease
executing chromatin degradation in context of apoptotic and
necrotic cell death.
MATERIALS AND METHODS
Ethic Statement
Themouse study was approved by TheNational Animal Research
Authority (NARA) (approval ID: 07/11167, ID-178).
Murine Tissue Samples
Female BW and female age-matched BALB/c mice were
purchased from Jackson Laboratory, Bar Harbor, Main, USA.
Kidney tissue was collected as described (Fenton et al., 2009),
and BW mice were grouped according to stages of murine
lupus nephritis. Group 1 pre-nephritic mice (no glomerular
deposits of chromatin or IgG), Group 2 mice with mesangial
nephritis (mesangial deposits of chromatin-IgG complexes), and
Group 3 mice with end-stage disease (deposits of chromatin-IgG
complexes in mesangium and in GBM, Fenton et al., 2009).
Proteins and Antibodies
The recombinant proteins used in this study were: human TNFα
(210-TA) and IL-1β (201-LB 1) from R&D system (Minneapolis,
MN, USA), and Fas ligand (FasL) protein (ab109359) from
Abcam (Cambridge, UK). Caspase 3 control cell extracts
(untreated and cytochrome c treated Jurkat cells) were obtained
from Cell Signaling Technology (Boston, USA). Alexa Fluor R©
488 annexin Vwas purchased from Life Technologies (California,
USA). Kineret (anakinra)—IL-1 receptor antagonist (IL-1Ra) was
obtained from SOBI, Sweden.
The following antibodies were used in this study: rabbit
anti-DNase I (ab113241, Abcam-Cambridge, UK), goat anti-
Trap1(sc-69289), and rabbit anti-DNase I (sc30058) from (Santa
Cruz, Texas 75220U.S.A), rabbit anti-DNase I (LS-B4846), rabbit
anti-FasR (LS-C152529, SC-74540), rabbit anti-FasL antibody
(LS-C176019), mouse anti-FasL antibody (LS-C35867), and
mouse anti-caspase 3 antibody (LS-B2125) were from Lifespan
Biosciences (Seattle, WA). Cleaved caspase 3-specific antibody
(9661) were from Cell Signaling Technology (Europe, B.V.),
rabbit anti-actin antibody (A2066) from Sigma-Aldrich (St.
Louis, MO) and mouse IL-1 beta /IL-1F2 Antibody (AF-401-NA)
from R&D System. Alexa 595-conjugated anti-rabbit IgG, Alexa
488-conjugated anti-goat IgG, DAPI and Alexa 488-conjugated
anti-mouse IgG secondary antibodies were all from Invitrogen
(California, USA). Alexa Fluor R© 488 annexin V was purchased
from Life Technologies (California, USA), HRP-conjugated anti-
rabbit IgG were from Invitrogen (California, USA), and HRP-
conjugated anti-mouse IgG were purchased from Dako (Oslo,
Norway).
Cell Culture Experiments
Primary human renal proximal tubule epithelial cells (RPTEC)
(Clontec, Lonza, Basel, Switzerland) have recently been validated
for the present experiment (Thiyagarajan et al., 2015). The cells
were grown in Clontec REGMTM BulletKit (CC-3190) containing
Renal Epithelial Cell Basal Medium with the following growth
supplements: hEGF, Hydrocortisone, Epinephrine, Insulin,
Triiodothyronine, Transferrin, GA-1000, and fetal bovine serum,
at 37◦C in 95% humidified air and 5% CO2. The cells were
grown to 80% confluence (without growth arrest) and stimulated
with TNFα (0, 20 ng/ml) or IL-1β (0, 2.5 ng/ml), if not otherwise
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stated in the text. These concentrations were based on results
from serial-dilution experiments as demonstrated below. The
cells were harvested at 24 and 48 h for mRNA analysis by qPCR
and for protein expression analysis by Western blot and confocal
microscopy. All cell stimulation experiments were performed in
triplicates and repeated at least three times.
Short Interference RNA (siRNA)
Transfection
In this study, 2 × 105 cells/well in six-well dishes and 2 × 104
cells/well in confocal plates were seeded 24 h before transfection.
After 24 h the media was removed and transfection was
proceeded with fresh media containing 20 ng/ml TNFα without
and with 20 nM scrambled smart pool DNase I siRNA or IL-1β
siRNA (Dharmacon) and negative siRNA control (Sigma) using
Lipofectamine 2000 (Invitrogen). The cells were harvested after
48 h after transfection. siRNA against P62 was used as a positive
control for transfection in separate wells.
RPTEC Stimulation with IL-1β in Presence
of IL-1 Receptor Antagonist
RPTEC were grown to 80% confluence and cells were stimulated
with 2.5 ng/ml of IL-1β alone or together with 200 ng/ml of
IL-1 receptor antagonist (IL-1Ra). Cells were harvested after
0-6-12-24-42-48 h and analyzed by qPCR.
ELISA
RPTEC were grown to 80% confluence and cells were stimulated
with 20 ng/ml of TNFα for 48 h. Cell supernatant and cell
lysate from both unstimulated and TNFα stimulated cells were
analyzed for IL-1β using IL-1β Quantikine ELISA kit from R&D
systems. Quantitative determination of human IL-1β in both
cell supernatant and cell lysate were performed according to
the instruction by the manufactures. Experiments were run in
triplicates and results were represented from two individual
experiment.
Stimulation of RPTEC with TNFα and
Subsequent Incubation with Fas Ligand
For the FasL experiment, RPTEC were grown to 80% confluence
and cells were stimulated with 20 ng/ml of TNFα for 48 h.
After 48 h of stimulation, RPTEC were incubated with various
concentrations of FasL protein (0, 25, 125 ng/ml) and grown for
48 h. Thereafter the cells were harvested and stored at −80◦C.
The apoptotic cells were analyzed and counted using TUNEL
assay and Annexin V staining.
RNA Isolation and cDNA Synthesis
Total RNAwas isolated fromRPTEC using TRIzol R© (Invitrogen,
CA, US), as described by the manufacturer. RNA quality
and concentration were determined spectrophotometrically by
Nano Drop (Nano Drop technologies, Wilmington, USA).
RNA samples were reverse-transcribed with random primers
using High Capacity cDNA Reverse Transcription kit (Applied
Biosystems, Foster City, USA).
Gene Expression Analyses
Quantitative real time PCR (qPCR) was performed using ABI
Prism 7900HT Sequence Detection System (Applied Biosystems).
Pre-designed FAM-labeled gene expression assays (Applied
Biosystems) were purchased and accession numbers for human
analyses are given in Table 1. TATA binding protein (TBP) was
used as endogenous control. The relative expression levels were
calculated using the ddCT method.
Western Blot
For Western blot analysis, cells were harvested using LDS buffer
(Invitrogen) and the protein concentration was determined
using protein quantification assay from Macherey-Nagel
(Duren, Germany) according to the manufacturer instruction.
Approximately 10 µg protein per well were loaded onto a 4–12%
Nu PAGE Bis-Tris gel (Invitrogen). SDS-PAGE and Western
blotting were performed according to standard procedures as
described in detail (Kalaaji et al., 2006) and actin was used as a
loading control.
Confocal Microscopy
RPTEC were seeded in a special 8µ well-slide (IB80826)
from Ibidi (Munich, Germany). The cells were fixed in
4% paraformaldehyde (KEBO, Oslo, Norway) in 1xPBS and
incubated for 10min on ice. The cells were permeabilized using
0.1% Triton X-100 (VWR International Oslo, Norway) in PBS for
5min, followed by blocking in 3% BSA for 30min and incubation
with the appropriate primary and secondary antibodies for
60 and 30min, respectively. Protein localization was detected
using Zeiss-LSM510 Meta confocal microscopy (Oberkochen,
Germany).
Immunohistochemistry (IHC) Analyses of
Murine Kidneys
Immunohistochemical (IHC) staining of DNase I was performed
as described and Polink-2 Plus HRP with DAB kit (Newmarket
Scientific, UK) was used as detection system. IHC staining of
IL-1β was performed on frozen kidney sections as previously
described (Hedberg et al., 2013).
TABLE 1 | Primer-probes used in this study, and their accession number.
Primer-Probes Accession number
DNaseI Hs00173736_m1
TRAP1 Hs00212476_m1
TBP (house-keeping gene) Hs00427621_m1
FASR Hs00236330_m1
Caspase-3 Hs00234385_m1
Caspase-7 Hs0016152_m1
Caspase-9 Hs00154261_m1
Bcl2 Hs00608023_m1
IL-1beta Hs01555410_m1
FASL Hs00181225_m1
P62 Hs00177654_m1
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Chromatin Immuno-Precipitation (ChIP)
The chromatin immuno-precipitation (ChIP) experiment was
performed using anti-DNase I antibody as the assay-specific
antibody, or non-specific rabbit IgG immunoglobulins as a
negative control. Sheared chromatin and ChIP using anti-histone
H3 antibodies were included as positive controls. The gene to
which DNase I was bound was identified by qPCR. The ChIP
assay was performed using unstimulated RPTEC or RPTEC
stimulated with 20 ng/ml of TNFα. Cells were harvested 48 h
after stimulation, and a Magna ChIP A assay (Merck Millipore,
MA, USA) was performed according to the manufacturer’s
protocol. Briefly, proteins were cross-linked to the DNA with
formaldehyde, cells were lysed, and samples were sonicated
twice for 30 s on ice at a 22-mm amplitude using a Soniprep
150 (MSE, London, UK). Samples were incubated with 5.0 µg
of rabbit polyclonal anti-DNase I antibody (ab113241 Abcam
Inc., MA, USA) and with 5.0 µg of rabbit polyclonal anti-
DNase I antibody (sc30058) with appropriate controls. Immuno-
precipitates were enriched with protein A magnetic beads.
Subsequently, chromatin complexes were eluted, the crosslinks
were reversed, and DNAwas isolated. The presence of FasR DNA
was evaluated using qPCR with primers corresponding to the
FasR promoter region (5′ GGGTCTTCCTCATGGCACTAAC 3′
and 3′CTCCTGAGGGCTTTCCATCAC 5′). Thereafter, samples
were loaded on a 2% agarose gel and visualized using ProXima
C16 software version 3.0 (Isogen Life Science, De Meern, The
Netherlands).
Annexin V Staining
Annexin V staining was performed according to the
manufacturer’s instructions. In short, unstimulated, TNFα-
stimulated or TNFα-stimulated in presence of FasL, adherent
and non-adherent RPTEC were washed in cold phosphate-
buffered saline (PBS). Washed non-adherent cells were
centrifuged, the supernatant discarded, and the cell-pellet was
resuspended in annexin-binding buffer (10mMHEPES, 140mM
NaCl, 2.5mM CaCl2, pH 7.4). Adherent and non-adherent
RPTEC were then diluted to a cell density of about ∼1 × 106
cells/ml. In situations where cell death was marginal, all non-
adherent RPTEC were pelleted and subjected to analyses. Five
microliters of Alexa Fluor R© 488 annexin V were added to each
100 µl of cell suspension before the cells were incubated at room
temperature for 15min. Next, the cells were subjected to DAPI
for 1min and washed with annexin-binding buffer. The non-
adherent cells were placed on a slide. Both the non-adherent and
adherent annexin V and DAPI stained RPTEC were subjected
to a Carl Zeiss LSM 700 confocal microscopy for fluorescence
detection.
Terminal Deoxynucleotidyl Transferase
dUTP Nick End Labeling (TUNEL) Assay
The terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) kit was purchased from Roche (Indiana, USA)
and the assay was performed according to the manufacture’s
instruction for both non-adherent and adherent cells. Briefly,
unstimulated, TNFα stimulated and TNFα stimulated and
FasL treated RPTEC cells were washed before the adherent
cells were fixed in 4% paraformaldehyde (PFA) in PBS for
10min on ice. The non-adherent cells were fixed with 2%
PFA for 60min in room temperature prior to centrifugation
and removal of supernatant. The cells were permeabilized
using 0.1% Triton X-100 (VWR International) in PBS for
5min. The cells were subsequently treated with TUNEL Mix
containing TUNEL label (11767291910; Roche) and the terminal
deoxynucleotidyl transferase enzyme (11767305001; Roche), and
incubated at 37◦C for 1 h. The cells were washed with PBS
and nuclei were stained by DAPI and subsequently subjected
to confocal microscopy using the Carl Zeiss LSM 700 confocal
microscopy. As a positive control in the TUNEL assay, RPTEC
were exposed to 10U recombinant DNase I to induce single-
stranded (TUNEL-positive) nicks, and the negative control was
represented by TUNEL in absence of terminal deoxynucleotidyl
transferase.
Caspase GLO 3/7 Assay
RPTEC were treated with 20 ng/ml of TNFα with or without
125g of FasL for 48 h. Following treatments, caspase 3/7 activity
were measured using the Caspase-Glo 3/7 assay kit (Promega,
Madison USA). Briefly, plates with cells were removed from the
incubator and allowed to equilibrate to room temperature for
30min. Caspase-Glo reagent (100 µl) was added to each well
before it was gently mixed with a plate shaker at 300–500 rpm
for 30 s. The cells were then incubated at room temperature
for 30 min−1 h. The luminescence of each sample wasmeasured
in a Clariostar microplate reader (BMG-Labtech, Ortenberg,
Germany). The experiments were performed in triplicate and
repeated in three independent experiments.
Statistics
Graph pad Prism was used to calculate the significance and
the data are presented as mean of three parallels (± SD). An
unpaired t-test was performed to test differences between the
cytokine stimulated/siRNA transfected and non-transfected cells
and for ELISA. One-way ANOVA with Dunett post-hoc test
was performed at different concentrations of cytokines to non-
stimulated cells and for cas3/7 GLO Assay. For each parameter;
p < 0.05 was considered significant and represented as ∗. If P-
value is ≤ 0.05 represented as ∗ ≤ 0.005 as ∗∗ and P-value ≤
0.0005 as ∗∗∗. All observations were included and Spearman was
used for significance testing.
Fuji Image J programwas used tomeasure the nuclear staining
intensity for all the confocal images.
RESULTS
Stimulation of RPTEC with TNFα Promotes
Nuclear Translocation of the DNase I
Protein and Increased Expression Levels of
DNase I, IL-1β, and FasR
As we have previously demonstrated (Thiyagarajan et al.,
2015), stimulation of RPTEC with 20 ng/ml of TNFα
in vitro for 48 h upregulates DNase I protein (Figure 1A).
Nuclear intensity of DNase I after TNFα stimulation shows a
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FIGURE 1 | Stimulation of human renal proximal tubular epithelial cells (RPTEC) with TNFα enhances DNase I, FasR, and IL-1β expression levels and induces
translocation of the DNase I protein into the nucleus. Stimulation of RPTEC with 20 ng/ml of TNFα for 48 h enhances DNase I expression and induces translocation of
the DNase I protein into the nucleus. Trap1 staining was used as a cytoplasmic marker. Upper panel: unstimulated RPTEC; lower panel: TNFα stimulated RPTEC
(DNase I: red, Trap 1: green) (A). Intensity of nuclear DNase I staining was measured using ImageJ (B). TNFα stimulation enhances mRNA expression level of DNase I
(C). In addition, the mRNA expression levels and protein expression (ELISA) levels of IL-1β, represented from two individual experiments (D,E, respectively), were
increased. At the same time, expression levels of FasR mRNA and protein level were significantly upregulated in TNFα-stimulated cells (F, G, respectively).
Significances: *P < 0.05; ***P < 0.0005.
significantly higher staining in the nuclei of TNFα stimulated
cells (Figure 1B). Stimulation of RPTEC with 20 ng/ml of
TNFα significantly upregulates DNase I mRNA (Figure 1C).
Also, TNFα upregulates IL-1β mRNA levels (Figure 1D)
and IL-1β protein levels (Figure 1E) and translocates DNase
I into the nucleus (Figure 1A, Trap1 (green) is used as a
cytoplasmic marker). Because TNFα is a potent inducer
of apoptosis (Krown et al., 1996; He and Ting, 2002), the
nuclear translocation of DNase I in response to TNFα is
probably linked to an apoptotic process. Particularly, the
FasR mRNA (Figure 1F) and the FasR protein expression
levels (Figure 1G) were significantly upregulated in TNFα-
stimulated cells compared with unstimulated cells. As
shown in Supplementary Figure 1A, TNFα-stimulation of
RPTEC induced FAS gene expression in a dose-depended
manner. While FasR mRNA and FasR protein were constantly
expressed in unstimulated RPTEC and increased upon TNFα-
stimulation, FasL mRNA (qPCR, Supplementary Figure 1B)
were undetectable after stimulation of the cells by TNFα or by
IL-1β (Supplementary Figures 1B,C).
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Stimulation of RPTEC with IL-1β Promotes
Nuclear Translocation of DNase I and
Upregulation of FasR Expression Levels
Since TNFα-stimulation of RPTEC upregulates IL-1β expression
levels (Figures 1D,E) (Turner et al., 2007; Thiyagarajan et al.,
2015), we analyzed whether IL-1β was involved in regulation
of DNase I expression levels and/or its nuclear translocation.
As shown in Figure 2A, IL-1β-stimulation did not significantly
affect expression levels of DNase I in situ as demonstrated by
confocal microscopy (Figure 2A). However, nuclear intensity
measurements of DNase I after IL-1β stimulation show that
IL-1β clearly promotes a nuclear translocation of DNase I
(Figures 2A,B and Supplementary Figures 2A,B). Percentage
of nuclear stained cells in stimulated vs. unstimulated cells
were calculated and showed nuclear staining of almost
85% of stimulated cells compared to unstimulated cells
(Supplementary Figure 2A). IL-1β did not affect the DNase
I mRNA (Figure 2C), nor the DNase I protein expression
levels significantly (Figure 2D). However, Importantly, IL-
1β-stimulation induced a significant upregulation of FasR
mRNA (Figure 2E) and FasR protein levels (Figure 2F),
while it did not affect FasL expression levels in RPTEC
(Supplementary Figures 1C). Interestingly, low doses of IL-1β
were sufficient to induce upregulation of FasR mRNA levels
(Figure 2E, Supplementary Figure 3A). Corresponding mRNA
levels of IL-1β in response to different doses of IL-1β stimulation
are demonstrated in Supplementary Figure 3B. This experiment
indicates that as little as 0.037 ng/ml is sufficient to significantly
upregulate both FasR and IL-1β mRNA levels above limits
necessary for DNase I translocation. These data are important
for understanding the results of experiments where TNFα-
stimulation of RPTEC was intended to be inhibited with siRNA
specific for IL-1β, or by addition of IL-1Ra (see below). Further
studies are therefore needed to understand if endogenous, newly
synthesized IL-1β is important for DNase I translocation (studies
in progress).
De Novo Synthesis of DNase I Is Not
Essential for Nuclear Translocation of
DNase I Nor for Upregulation of FasR
Levels
To determine if newly synthesized DNase I was required
for DNase I nuclear translocation, RPTEC were stimulated
with TNFα and simultaneously transfected with DNase I-
mRNA-specific or IL-1β-mRNA-specific siRNAs (Figure 3A).
Furthermore, analyses were undertaken to determine if nuclear
translocated DNase I is responsible for upregulation of the
FAS gene. Thus, we investigated the links between TNFα, IL-
1β, DNase I expression levels and its nuclear translocation and
possible ability to enhance FasR expression levels.
Confocal microscopy analyses of DNase I (red) was performed
on RPTEC after stimulation with TNFα and the effect of
simultaneous transfection of the cells with DNase I mRNA-
specific or IL-1β mRNA-specific siRNAs. Trap1 staining
(green) was used as a cytoplasmic marker. Unstimulated
RPTEC presented weak cytoplasmic DNase I expression but
no nuclear DNase I staining (Figure 3A, first row). After
stimulation of RPTEC with TNFα alone, the DNase I protein
expression levels increased, DNase I translocated into the nuclei
(Figure 3A, second row), and DNase I mRNA levels increased
slightly (Figure 3C). After TNFα-stimulation and simultaneous
transfection of the cells with DNase I mRNA-specific siRNA,
DNase I mRNA expression levels were reduced to a level below
that in unstimulated cells (Figure 3C), however, nuclear DNase I
translocation was still weakly detectable (Figure 3A, third row).
Importantly, transfection of these cells with DNase I siRNA did
not affect the IL-1β mRNA levels (Figure 3C). Nuclear intensity
measurement of DNase I in RPTEC cells transfected with DNase
I and IL1β siRNA were represented (Figure 3B). This explains
why DNase I siRNA does not interfere with endogenous IL-1β-
mediated upregulation of FasR mRNA levels (Figure 3C). Thus,
DNase I that translocates into the nucleus most likely derives
from previously transcribed and stored DNase I protein, and its
translocation is promoted by IL-1β.
Whether nuclear DNase I translocation is an IL-1 receptor-
depending process was analyzed by addition of IL-1Ra to RPTEC
stimulated with IL-1β. This resulted in strong reduction in IL-
1β mRNA levels (Supplementary Figure 3C). However, IL-1Ra
was not sufficient to eliminate the upregulation of IL-1β gene
expression levels completely in response to IL-1β-stimulation in
RPTEC (Supplementary Figures 3C,D) or to TNFα-stimulation
(as demonstrated in Supplementary Figure 3D). This may
probably explain why addition of IL-1Ra did not markedly affect
mRNA levels of FasR in IL-1β- or in TNFα-stimulated cells
(Supplementary Figure 3E).
RPTEC stimulated with TNFα and transfected with DNase
I specific siRNA upregulated FasR mRNA significantly
(Figure 3C) in contrast to the FasR protein expression level
(Figure 4A) which remained unaffected in harmony with the
reduced DNase I translocation in this experiment. Importantly,
prevention of nuclear DNase I translocation by IL-1β siRNA
in RPTEC also reduced TNFα mediated upregulation of FasR
mRNA level (Figure 3C). In addition, FasR protein expression
was reduced (Figures 4B,C).
Different concentration of TNFα stimulation upregulates
IL-1β and FAS mRNA significantly in other cell lines
(Supplementary Figure 4A). In addition, nuclear DNase I
translocation and its association with IL-1β mRNA levels and
protein expression were also observed in vivo as demonstrated
by data in Supplementary Figure 4. IL-1β gene and protein
expression are shown in young (< 6 weeks) and older mice
(20 weeks) (Supplementary Figures 4A,B, respectively) and
demonstrate higher IL-1β levels in 20 weeks old mice compared
to young mice (Supplementary Figures 4A,B, for IL-1β mRNA
and IL-1β protein in situ). A low amount of DNase I nuclear
staining was seen in animals with low levels of renal IL-1β
expression (Supplementary Figure 4C), compared to animals
with higher IL-1β expression levels in which tubular cell nuclei
were extensively stained (Supplementary Figure 4C, 20 weeks).
ChIP Analysis Revealed that DNase I
Bound to the FasR Promotor Region
As demonstrated above, IL-1β induced nuclear DNase I
translocation in TNFα-stimulated RPTEC, accompanied by
upregulation of FasR mRNA and protein expression levels.
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FIGURE 2 | Stimulation of RPTEC with IL-1β promotes nuclear translocation of DNase I and upregulatesFasR expression levels. Stimulation of RPTEC with 2.5 ng/ml
of IL-1β for 48 h did not upregulate DNase I protein expression but imposed nuclear translocation of DNase I as demonstrated by confocal microscopy (DNase I: red,
Trap 1: green) (A). Intensity of nuclear DNase I staining was measured using ImageJ (B). Stimulation of RPTEC with 2.5 ng of IL-1β for 48 h did not affect DNase I
mRNA (C) and protein expression levels (D). Importantly, enhanced FasR mRNA (E) and protein levels (F) were observed in cells after IL-1β stimulation. In this
experiment, a nearby full FasR mRNA response was achieved when stimulating the RPTEC cultures with 1.25 ng/ml of IL-1β (E). Significances: *P ≤ 0.05; ***P
≤ 0.0005.
Since translocated nuclear DNase I in this experiment was
enzymatically inactive and its appearance in the nuclei did not
result in chromatin fragmentation, (Thiyagarajan et al., 2015
see below), we hypothesized that nuclear DNase I was involved
in regulation of the FAS gene. To test this hypothesis ChIP
analyses was performed (Figure 4D) by using non-specific IgG
(neg.ctr), one anti-55 kDa DNase I (Santa Cruz (sc)), and
one anti-DNase I antibody specific for translocated DNase I
[52 kDa DNase I, Abcam (ac)]. To determine if DNase I
was associated with FasR promoter sequences in chromatin
fragments precipitated by the antibodies, FasR specific qPCR
was performed (Figure 4D, upper part represent data from
unstimulated RPTEC and lower part demonstrate data from
TNFα-stimulated RPTEC). FasR-specific qPCR on chromatin
from unstimulated RPTEC immunoprecipitated with control-
IgG and ac-DNase I was negative (neg.ctr). Also the anti-DNase I
specific antibody from Santa Cruz (sc) did not precipitate FasR
sequences. In contrast, the anti-DNase I antibody specific for
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FIGURE 3 | The siRNA against IL-1β nearby abolished the nuclear translocation of DNase I. Confocal microscopy analyses of DNase I (red) was performed on RPTEC
stimulated with TNFα and simultaneously transfected with DNase I-specific or IL-1β-specific siRNAs. Trap1 staining was used as a cytoplasmic (green) marker.
Unstimulated RPTEC present weak DNase I expression and no nuclear DNase I staining (A, first row). When the RPTEC were stimulated with TNFα, DNase I protein
expression increased, and DNase I translocated into the nucleus (A, second row). Treating the cells with TNFα and transfecting with DNase I mRNA-specific siRNA,
reduced the DNase I protein expression and nuclear DNase I translocation (A, third row). In addition, TNFα stimulation of IL-1β siRNA-transfected RPTEC reduced
nuclear translocation of DNase I (A, fourth row). These results were confirmed with intensity measurements of nuclear DNase I staining (B). DNase I, FasR and IL-1β
mRNA levels were analyzed in RPTEC stimulated with TNFα. In addition, mRNA levels of RPTEC stimulated with TNFα and simultanously transfected with DNase I and
IL-1β mRNA-specific siRNA are shown. As a control, RPTEC were treated with negative siRNA. (C). TNFα-stimulation in the presence of DNase I-specific siRNA
resulted in the reduction of DNase I mRNA level, while IL-1β and FasR mRNA levels were unaffected and remained the same as in TNFα-stimulation alone. In contrast,
presence of IL-1β mRNA-specific siRNA in TNFα-stimulated RPTEC resulted in a significant reduction of FasR compared to TNFα stimulation alone, while DNase I
gene expression level was unchanged. As expected, IL-1β mRNA expression level was reduced (C). Significance: *P ≤ 0.05; **P ≤ 0.005; ***P ≤ 0.0005; ns P > 0.05.
translocated DNase I precipitated FasR sequences in chromatin
from TNFα-stimulated RPTEC. The qPCR on purely sheared
chromatin demonstrated presence of FasR DNA sequences
(Input sample) and as a positive control, an anti-histone H3
antibody precipitated chromatin fragments that yielded a positive
FasR-specific qPCR (pos ctr).
Thus, combining the results demonstrated that DNase I
translocates into the nuclei in response to IL-1β, probably
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FIGURE 4 | DNase I binds to the FasR promotor region. TNFα stimulated
RPTEC transfected with DNase I-specific siRNA did not alter FasR protein
expression severely (A). Stimulation of RPTEC with TNFα and transfecting with
IL-1β mRNA-specific siRNA, left the FasR protein at the same level as in
unstimulated cells (B,C, right panel). However, stimulation of RPTEC with
TNFα increased FasR expression (B,C, middle panel).The ChIP experiment
was performed to analyse the context between nuclear DNase I translocation
and upregulation of FasR (D). FasR promoter-specific qPCR on sheared
chromatin from unstimulated RPTEC immunoprecipitated with non-specific
IgG was close to negative (Neg. ctr.), similar to sheared chromatin from
unstimulated cells immunoprecipitated with the anti-DNase I IgG (Abcam
(ac)-DNase I). ChIP using anti- DNase I antibody (Santa cruz (sc)-DNase I) and
non-specific IgG (Neg. ctr) did not precipitate FasR-containing DNA
sequences for the TNFα-stimulated cells, while the anti-DNase I antibody
(ac-DNase I) precipitated DNase I in complex with FasR promoter sequences.
qPCR on sheared chromatin demonstrated presence of FasR promoter
DNA sequence in this sample (Input sample). As a positive control,
anti-histone H3 antibody-precipitated chromatin fragments were used
(D, Pos. Ctr.).
binding to the promoter region of the FAS gene where it may
exert a function as a transcription factor for FasR.
Apoptosis in RPTEC Is Induced When
DNase I Translocates to the Nucleus and
Upregulates FasR in Presence of
Exogenous FasL
In a previous study, we demonstrated that TNFα-stimulation
did not directly induce apoptosis in RPTEC (Thiyagarajan et al.,
2015). In light of the results described above, we analyzed
a link between DNase I translocation and upregulation of
FasR in absence of detectable apoptosis. In-depth analyses of
several apoptotic, parameters in stimulated cells were examined.
After TNFα-stimulation, a significant upregulation of FasR
(Figure 1F), caspase 3 and caspase 7 mRNA levels (Figure 5A)
was shown. We did not detect activated caspase 3 levels
upon TNFα-stimulation (Figure 5B). However, after TNFα
stimulation in the presence of 125 ng of FasL, RPTEC showed an
increased caspase 3/7 activity compared to the unstimulated and
TNFα stimulated cells by Caspase GLO 3/7 assay (Figure 5C).
In order to ascertain that TNFα does not induce apoptosis
in RPTEC, other relevant apoptotic parameters were analyzed
(Figure 5D). Since RPTEC grow as adherent cells and become
non-adherent by cell death, quantification of non-adherent cells
is indicative of cell death. The numbers of non-adherent RPTEC
were negligible and very similar in the unstimulated or TNFα-
stimulated RPTEC cultures, thus arguing against an apoptotic cell
death in response to TNFα.
In an analogous approach, the TUNEL assay was negative for
unstimulated and TNFα-stimulated adherent cells (Figure 5D,
upper panel), while inconclusive for non-adherent cells
(Figure 5D, lower panel) because of no or marginal amounts of
cells in the culture medium.
Data presented so far demonstrate that TNFα-stimulation
alone upregulates the FasR protein expression levels, but did not
render the cells TUNEL positive. Therefore, RPTEC demonstrate
a relative resistance to TNFα-mediated apoptosis, consistent
with previous observations for tubular cells (Boonstra et al.,
1997; Jo et al., 2002; Kunter et al., 2005). Resistance to TNFα-
induced apoptosis could also be explained by the fact that RPTEC
do not constitutively express FasL, which was confirmed by
gene expression analysis (Supplementary Figure 1B). In order
to induce apoptosis in RPTEC, we added recombinant human
FasL to the cells stimulated with TNFα. As demonstrated in
Figure 5E, FasL did not bind to unstimulated RPTEC, while
after TNFα-stimulation; FasL bound significantly to the cell
membranes and was in confocus with FasR. To identify whether
the interaction of FasL with FasR induced overt apoptosis,
several apoptotic markers were analyzed after TNFα- and FasL-
stimulation of RPTEC. In these cells, mRNA levels of caspases
3 and 7 were significantly upregulated in contrast to the
anti-apoptotic Bcl2 mRNA that was significantly reduced in
presence of FasL (Figure 5A). However, as observed for TNFα-
stimulated RPTEC, we could not detect activated caspase 3 in
these cells after treatment with exogenous FasL by Western blot
(Figure 5B). In Figure 5F, it is demonstrated that unstimulated
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FIGURE 5 | TNFα stimulation upregulates the FasR protein and caspase 3 mRNA expression levels in RPTEC, but the cells undergo apoptosis only in the presence of
exogenous FasL. FasL interaction with upregulated Fas receptor (FasR) is required to induce apoptosis in RPTEC stimulated with TNFα. In TNFα-stimulated RPTEC,
caspase 3 and 7 mRNA were significantly upregulated, the mRNA level of caspase 9 did not changed while Bcl2 were significantly downregulated. Additional
treatment with 125 ng FasL resulted in upregulation of caspase 3 and caspase 7 mRNA levels and further downregulation of Bcl2 mRNA levels (A). Notably, activated
caspase 3 was not detected in unstimulated RPTEC (B, lane 1), RPTEC stimulated with TNFα (B, lane 2) as well as in RPTEC stimulated with TNFα and treated with
FasL (B, lane 3). Controls 1 and 2 were cytochrome c treated Jurkat cells (activated caspase 3 positive, II) and untreated Jurkat cells (activated caspase 3 negative, I),
lane C1 and C2 respectively. Caspase GLO 3/7 Assay were performed in RPTEC with TNFα stimulation alone and with TNFα stimulation in the presence of FasL. The
results are represented from three individual experiments in relative light units (RLU) and values were subtracted from blank (media without cells) (C). In adherent
unstimulated or TNFα-stimulated RPTEC, no cells were TUNEL positive (D, upper panel). In non-adherent and unstimulated RPTEC, only very few cells could be
observed and they were marginally TUNEL positive (D, lower panel). RPTEC stimulated with TNFα revealed a single detectable non-adherent cell that was TUNEL
positive. The cells were counterstained with DAPI to ascertain their presence. As demonstrated by confocal microscopy, FasL did not bind to unstimulated RPTEC,
while stimulation with TNFα resulted in strong binding of exogenously added FasL to the cell membranes (E, upper and lower panel, respectively). The FasL-FasR
interaction induced apoptosis in RPTEC. Unstimulated adherent cells were TUNEL negative, while Annexin V stained weakly adherent unstimulated RPTEC. In this
context, no non-adherent cells could be detected. When stimulating RPTEC with TNFα followed by addition of FasL, both adherent and non-adherent cells were
TUNEL-positive (F). Similarly, TNFα-stimulated and FasL-treated adherent and non-adherent RPTEC were strongly Annexin V-positive. The cells were counterstained
with DAPI to ascertain their presence. Significances: *P ≤ 0.05; ***P ≤ 0.0005.
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cells were both TUNEL and Annexin V negative. However,
both adherent and non-adherent TNFα-stimulated cells to which
FasL was added became TUNEL-positive and Annexin-positive
(Figure 5F). In this experiment, we did not observe non-adherent
cells with intact morphology, rather, Annexin V stained mostly
microparticle-like (Beyer and Pisetsky, 2010; Dey-Hazra et al.,
2010; Dinkla et al., 2013) or blebs-like (Cocca et al., 2002)
structures in the culture supernatant (Figure 5F, lower panel).
To summarize, the data demonstrate that TNFα-stimulation
upregulates FasR indirectly through TNFα-mediated
upregulation of IL-1β in RPTEC. IL-1β promotes nuclear
translocation of DNase I, which leads to the upregulation
of FasR. This cascade makes the cells highly susceptible to
FasL-mediated apoptosis.
DISCUSSION
Data presented in this study provide new insight into regulation
and function of renal DNase I. The data describe the influence
of pro-inflammatory cytokines on DNase I expression, on
subcellular localization and on a new and potentially important
biological effect of DNase I. TNFα-stimulation of RPTEC
enhanced DNase I and IL-1β mRNA and protein expression,
and translocated DNase I into the nucleus with a hitherto
undescribed MW of 52 kDa (Thiyagarajan et al., 2015).
Stimulation of RPTEC with IL-1β translocated DNase I without
enhancing its gene expression, indicating that TNFα-stimulation
translocated DNase I through enhanced expression of IL-1β.
Transfection of RPTEC with siRNA specific for DNase I or IL-
1β mRNAs demonstrated that enhanced expression of DNase
I and translocation of DNase I derived from two independent
processes. Enhanced DNase I gene expression is a direct
response to TNFα, independent from the effect of IL-1β, while
translocation into the nucleus is a direct effect of endogenously
expressed IL-1β. Thus, aside from demonstration that DNase
I translocated into the nucleus by confocal microscopy, an
even stronger argument for translocation comes from our
ChIP experiment with anti-DNase I antibody. While applied to
unstimulated cells, the ChIP experiment was negative for FasR
promoter sequences, corresponding to the results showing that
FasR expression levels was not upregulated. The same experiment
using cells stimulated with TNFα demonstrated that DNase I
bound to FasR promoter sequences, correlating with the results
showing upregulation of FasR protein levels.
TNFα is a known inducer of apoptosis (Bradham et al., 1998;
He and Ting, 2002; Schlatter et al., 2011). Nuclear translocation
of DNase I as reported here could be interpreted as a part of
an induced apoptotic cascade leading to apoptotic chromatin
fragmentation. However, we did not observe signs of apoptosis
in RPTEC upon TNFα-stimulation as demonstrated by absence
of apoptotic DNA fragmentation (Thiyagarajan et al., 2015),
negative TUNEL, absence of Annexin V-positive cells/blebs, and
by absence of morphological changes in RPTEC corresponding
to apoptosis. As has been published before, TNFα alone is not
sufficient to induce apoptosis in RPTEC in vitro unless the
cells are simultaneously treated with RNA and protein synthesis
inhibitors (Kunter et al., 2005). This is explained by the fact
that TNFα triggers two distinct signaling pathways leading either
to apoptosis or to activation of NF-κB transcription factors,
which will inhibit apoptosis through expression of anti-apoptotic
genes (He and Ting, 2002; Machuca et al., 2006; Schlatter et al.,
2011). In context of the present study, nuclear translocation
of DNase I was not accompanied by apoptosis. This is in
harmony with the fact that nuclear translocated DNase I has
a MW of 52 kDa and is enzymatically inactive, while DNase I
with endonuclease activity was located in the cytoplasm with
a MW of 40 kDa. The 55 kDa DNase I targeted by the Santa
Cruz antibody has been shown to be enzymatically inactive
(Thiyagarajan et al., 2015), and located in the cytoplasm. We
demonstrate a strong correlation between de novo expression of
IL-1β, nuclear translocation of DNase I, and enhanced expression
of FAS gene. This correlation was dependent on cytoplasmic
DNase I, but also of de novo synthesized DNase I since cells
stimulated by TNFα and transfected with DNase I siRNA
demonstrated low levels of cytoplasmic 40 kDa DNase I, and
weakly detectable translocated DNase I. On the other hand,
stimulation of RPTEC with TNFα and transfecting cells with IL-
1β siRNA resulted in increased DNase I expression, but blocked
DNase I translocation. Thus, the conclusion of these results
is that the nuclear translocated DNase I are directly involved
in upregulation of FasR. The ChIP experiments adds strength
to this assumption. Abcam anti-DNase I antibody precipitated
with FAS promoter gene sequences. Thus, an assumed IL-1β-
mediated modification of cytoplasmic DNase I into a 52 kDa
protein resulted in nuclear translocation and its binding to the
FasR promoter. The negative effect on this process exerted by IL-
1β-specific siRNA transfection harmonizes with the conclusions
that de novo synthesis of IL-1β accounted for the process that
enhanced FasR expression. Since stimulation of cells with IL-
1β directly upregulated endogenous IL-1β, this might mean that
translocation of DNase I is not dependent on interaction of IL-
1β with its cell membrane receptor. Rather, the direct effect
of TNFα on upregulation of de novo synthesized IL-1β may
indicate that IL-1β exerts its effect on DNase I translocation
unlinked from interaction with its receptor. As we have shown,
addition of IL-1Ra to TNFα-stimulated RPTEC did not affect
mRNA level of FasR. It can be explained by an insufficient
effect of IL-1Ra on IL-1β binding to its receptor, or may
indicate an IL-1receptor-independent mechanism of DNase I
translocation in TNFα-stimulated cells. The role of the IL-1β
receptor on the processes described here is currently under
investigation.
DNase I has also previously been suggested to act as a
transcription factor for FasR by Oliveri et al. (Oliveri et al., 2004;
Tinazzi et al., 2009). The authors demonstrated that recombinant
DNase Imay bind themannose 6-phosphate receptor followed by
increased surface expression of FasR. Whether the recombinant
DNase I added to the cell culture was indirectly or directly
involved in upregulation of the FasR was not determined.
However, the data presented here may envisage the basis for
the effect of DNase I in the Oliveri study. If recombinant
DNase I binds directly to the mannose 6-phosphate receptor,
this may enhance IL-1β production in the cells as has been
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demonstrated by Vidal-Vanaclocha et al. (1996). Similar to our
present study, endogenous de novo synthesis of IL-1β in response
to stimulation of the mannose 6-phosphate receptor is likely to
cause translocation of endogenous DNase I into the nucleus.
Thus, recombinant DNase I may drive this process, while
endogenous IL-1β fulfills it by translocating endogenous DNase
I to the nuclei where it may directly enhance FasR expression
(studies in progress).
Our data collectively demonstrate that nuclear translocation
of DNase I converts the protein from an endonuclease into
a protein functioning as a transcription factor regulating the
expression of the FAS gene. We therefore conclude that DNase I
likely has a dual biological effect; DNase I is involved in processes
initiating and priming the cells for apoptosis by increasing the
FasR expression and function (Wajant, 2002), in addition to its
well-known role in chromatin fragmentation in later phases of
the apoptotic process.
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Supplementary Figure 1 | Expression of FasR and FasL in RPTEC cells
stimulated with TNFα and IL-1β. FasR were upregulated in a dose dependent
manner in RPTEC stimulated at various concentration of TNFα (A). FasL mRNA is
not expressed in resting RPTEC, nor induced by 20 ng/ml of TNFα stimulation for
48 h. Data are shown in comparison to mRNA expression levels of FasR (B). FasL
mRNA is not expressed in resting RPTEC nor induced by 2.5 ng/ml of IL-1β
stimulation for 48 h (C). Data are shown in comparison to mRNA expression levels
of FasR. Significances: ∗P< 0.05; ∗∗∗P< 0.0005.
Supplementary Figure 2 | RPTEC stimulated with 2.5 ng/ml of IL-1β
translocates DNase I into the nucleus. The percentage of DNase I nuclear staining
were calculated in both unstimulated and IL-1β stimulated cells. An average of
85% cells had stained nucleus compared to the unstimulated cells (A). Various
confocal images show a strong nuclear DNase I staining in cells stimulated with
IL-1β compared to unstimulated cells (B).
Supplementary Figure 3 | FasR and IL-1β mRNA expression levels. FasR is
upregulated to near maximum levels upon stimulation of RPTEC with 0.037ng/ml
of IL-1β (A). Stimulation of RPTEC with serial dilutions (0.037–2.5 ng/ml) of IL-1β
demonstrates a dose-response relationship with endogenous IL-1β transcription
(B). IL-1 receptor antagonist (IL-1Ra) treatment of RPTEC stimulated with IL-1β
reduces endogenous IL-1β transcription rates up to 14 times (C). IL-1β stimulation
of RPTEC in presence of IL-1Ra reduces IL-1β transcription, while TNFα induced
IL-1β transcription was unaffected by IL-1Ra (D). Since IL-1β mRNA expression
was not completely lost in presence of IL-1Ra (see C), and as very small amounts
of IL-1β (<0.05 ng/ml, see B) upregulate FasR expression, expression of FasR in
RPTEC stimulated with IL-1β or TNFα and treated with IL-1Ra was unaffected
(E). Significances: ∗P< 0.05; ∗∗∗P< 0.0005
Supplementary Figure 4 | mRNA and protein expression levels of IL-1β and
in-vivo nuclear staining of DNase I in kidneys of pre-nephritic mice. mRNA levels of
FAS and IL-1β in HEK cells (Human Embryonic Kidney cell line), LNCaP cells
(Prostate cancer cell line) and MCF-7 cells (Breast cancer cell line) stimulated with
10 ng and 20 ng of TNFα (A). Notably, and in harmony with the assumption that
the pro-inflammatory cytokine IL-1β is involved in nuclear DNase I translocation
(see text), the renal mRNA (B) and protein (C) level of IL-1β was higher in kidneys
with nuclear DNase I than in kidneys with DNase I predominantly detected in the
cytoplasm (D). Significances: ∗P ≤ 0.05; ∗∗P ≤ 0.005; ∗∗∗P ≤ 0.001.
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